Literature DB >> 2117514

Clinical results with subcutaneous implants containing 3-keto desogestrel.

S E Olsson1, V Odlind, E Johansson.   

Abstract

Eight healthy women using one Silastic implant of 30 mm length filled with 3-keto desogestrel, the active metabolite of desogestrel, were studied for 36-664 days. The release rate of 3-keto desogestrel was quite constant and around 30 micrograms/day. No ovulations occurred. One woman was amenorrheic, while the others had different bleeding patterns, often with periods of spotting. No other side effects were recorded. The mean plasma levels of 3-keto desogestrel were 0.9 nmol/l after 1 month and 0.5 nmol/l after 12 months. 3-Keto desogestrel was less effective than testosterone, estradiol or levonorgestrel in displacing 3H-dihydrotestosterone from SHBG. It is concluded that contraception with 3-keto desogestrel delivered through an implant is a promising method for further investigation. With a single implant we found a duration of at least one year.

Entities:  

Keywords:  Biology; Bleeding--analysis; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Implants; Contraceptive Methods; Contraceptive Usage; Developed Countries; Diseases; Endocrine System; Europe; Evaluation; Examinations And Diagnoses; Family Planning; Hormones; Laboratory Examinations And Diagnoses; Method Acceptability; Northern Europe; Physiology; Progestational Hormones; Progesterone--analysis; Research Methodology; Scandinavia; Signs And Symptoms; Sweden

Mesh:

Substances:

Year:  1990        PMID: 2117514     DOI: 10.1016/0010-7824(90)90087-c

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  1 in total

1.  Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.

Authors:  Monica Dragoman; Kelsey Petrie; Anupama Torgal; Tiffany Thomas; Serge Cremers; Carolyn L Westhoff
Journal:  Contraception       Date:  2012-12-10       Impact factor: 3.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.